Dr. Aparna Sridhar, MD

Dr. Sridhar practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Sridhar's NPI, 1154526010, was assigned on June 19, 2007. Dr. Sridhar graduated from Mysore Medical College in 2005. Dr. Sridhar holds California license A116116.

Dr. Sridhar's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Sridhar's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Sridhar is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health Westwood OBGYN. Dmand AI also links Dr. Sridhar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sridhar practices, 2 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Sridhar's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Sridhar is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Sridhar's licenses on file in 2 states: California and New Jersey.

Dmand AI lists menopause among the conditions Dr. Sridhar treats.

CMS data shows 49 Medicare services from Dr. Sridhar across 3 procedure codes in 2024, for 42 Medicare patients. Medicare paid $2,181 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Sridhar in 2024. The largest group is 65 to 74, with 19 patients. 57% of them have high cholesterol, and 43% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sridhar's median patient age at 37, with 98% women.

In 2024, Dr. Sridhar wrote 57 Medicare Part D claims for 21 patients. 74% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $11,004 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sridhar for performance year 2024, reported as part of a group. Dr. Sridhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Sridhar, published from 2011 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Prostatectomy, Prostatic Neoplasms and United Kingdom. Dr. Sridhar has published most often in Lupus. Dr. Sridhar's most frequent co-authors are Andrew M. Kaunitz, MD, Andrea Ng, MD and Radhika D. Rible, MD.

Dmand AI links Dr. Sridhar to 2 clinical trials. Conditions studied include Anxiety Disorders, Contraception Behavior and Mental Disorders. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 3 general payments to Dr. Sridhar from 2 drug and device companies from 2018 to 2024. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $2,500.

Dmand AI lists 15 awards for Dr. Sridhar, most recently FOGSI Badlaav Achiever Award in 2024. Dr. Sridhar serves on ACOG Legislative Committee.

Dr. Sridhar graduated from Mysore Medical College in 2005. Dr. Sridhar is a member of American College of Obstetricians and Gynecologists and Society of Family Planning.

Dr. Sridhar is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.